In a strategic move towards refining our product offering, we're excited to share a significant evolution in our Uplift gummies. We are completely transitioning from Delta 8 THC to hemp-derived Delta 9 THC. This progression is underpinned by scientific advancements in hemp-based cannabinoid extraction and a commitment to legal compliance.

Cannabinoids, the chemical compounds within the cannabis plant, exhibit structural variability known as isomers. D8-THC and D9-THC are isomers with similar structures but differ in the placement of a double bond in their molecular chains. D9 has its double bond at the 9th carbon atom, whereas D8’s double bond is located on the 8th carbon atom, leading to distinct effects.

The specific structural features of D9 contribute to its heightened potency compared to D8. This structural distinction changes the interaction with the endocannabinoid system, resulting in a more pronounced psychoactive effect.
Despite maintaining the familiar 2.5mg THC content per gummy, this molecular refinement amplifies the overall potency, offering consumers an elevated and sophisticated experience.

Our decision aligns with the 2018 Farm Bill, a legislative framework that permits  products containing less than 0.3% hemp-derived Delta 9 THC by weight. This legal foundation ensures compliance and adherence to established regulatory standards, allowing us to introduce the D9 formulation.

The transition to hemp-derived Delta 9 THC seamlessly integrates into Uplift gummies while preserving essential characteristics. The tropical flavor, user-friendly convenience, and our commitment to health-conscious ingredients persist, ensuring a harmonious fusion of the new formulation with the foundational elements of our product. Uplift, now enriched with hemp-derived Delta 9 THC, signifies a calculated step forward in providing edibles that continue to harmonize with regulatory frameworks. Join us in celebrating this evolution, where excellence meets innovation in the world of Uplift.